← Alle mensen

EC

Enric Carcereny

9 publicaties

Publicaties op Oncologisch.com

Fase II Dose-Gerandomiseerde Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal ...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 oktober 2025
ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab...
Clinical cancer research : an official journal of the American Association for Cancer Research · 15 november 2024
Sotorasib 960 mg of 240 mg bij KRAS G12C NSCLC
European journal of cancer (Oxford, England : 1990) · 2024-09
Multi-regio transcriptomische subtypering bij chemo-IO bij NSCLC
Clinical cancer research : an official journal of the American Association for Cancer Research · 15 juli 2024
Canakinumab plus pembrolizumab-chemo bij gevorderd NSCLC: CANOPY-1 fase III
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 januari 2024
Durvalumab alleen of plus oleclumab/monalizumab na chemoradiatie bij NSCLC: COAST fase II
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 oktober 2022
Nivolumab plus ipilimumab als eerstelijns bij NSCLC: CheckMate 227 vierjaars
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2022-02
PALB2-expressie en platina-docetaxel werkzaamheid bij NSCLC
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2019-02
Economische analyse van eerstelijns erlotinib bij EGFR-gemuteerd gevorderd NSCLC
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2016-06